Results of tests using the cancer-proneBAC3F, mouse have had a major role in risk assessment of many chemicals. However, studies that reveal differences in metabolism of mice, rats, monkeys, and humans raise doubts about the relevance of the mouse experiments. In addition, epidemiologic studies of the morbidity and mortality of elicited.* Most of the tumors observed were nonmalignant. When the mice were exposed to 625 and 1250 ppm, the study was stopped at 60 and 61 weeks because tumors in the exposed mice were causing excessive mortality. The tumors were in many tissues and included alveolar (lung) and hepatocellular (liver) carcinomas. The B6C3F1 mice differ from some other mice and from humans and rats in possessing an endogenous murine leukemia virus (MuLV). This virus has been shown to have a substantial role in enhancing the incidence of malignant (thymus) lymphomas when the mice are exposed to butadiene.t The presence of the endogenous MuLV virus and its activation by butadiene exposure could also affect the incidence of other tumor types in exposed B6C3F1 mice.
elicited.* Most of the tumors observed were nonmalignant. When the mice were exposed to 625 and 1250 ppm, the study was stopped at 60 and 61 weeks because tumors in the exposed mice were causing excessive mortality. The tumors were in many tissues and included alveolar (lung) and hepatocellular (liver) carcinomas. The B6C3F1 mice differ from some other mice and from humans and rats in possessing an endogenous murine leukemia virus (MuLV). This virus has been shown to have a substantial role in enhancing the incidence of malignant (thymus) lymphomas when the mice are exposed to butadiene.t The presence of the endogenous MuLV virus and its activation by butadiene exposure could also affect the incidence of other tumor types in exposed B6C3F1 mice.
The B6C3F1 mice differ from rats, monkeys, and humans in a propensity to oxidize the monoepoxide to a diepoxide C4H602. This latter compound has been shown to participate in the formation of DNA-DNA and DNA-protein cross-links in the mouse. The final fate of much of the metabolites of butadiene is excretion in the urine as mercapturic acids formed by conjugation with glutathione. In the mouse urine a major part of the mercapturic acid conjugates involves the monoepoxide. In the monkey only trace levels of the monopoxide conjugate were found. The conjugate with the harmless hydrolysis product C4H802 predominated. In vitro studies with liver and lung microsomes have shown that metabolism of the butadiene monoepoxide in humans also proceeds through the pathway to the non-DNAreactive product.
The National Institute of Occupational Safety and Health (NIOSH) has based its "best estimate" of the carcinogenicity of butadiene solely on experiments on the B6C3F1 mouse. The results of rat, monkey, and human tests showing major differences in uptake, retention, and metabolism, and far less risk of cancer, have been disregarded.
As is customary, extrapolations from doses in mice to low doses in humans are made with the use of arbitrary models. One model gives the result that 45 years of exposure to 2 ppm of butadiene in the workplace should lead to 10,000 deaths of 10,000 workers. The 
